Skip to main content

Agilent and Proteome Systems Pen Mass Spec Software Agreement

NEW YORK, April 19 (GenomeWeb News) - Agilent Technologies and Proteome Systems will collaborate on a combined platform for glycoprotein analysis, the companies said today.

 

Under the terms of the agreement, Proteome Systems will make its GlycomIQ software compatible with Agilent's XCT, XCT Plus, and XCT Ultra ion-trap mass spectrometers, the companies said.

 

Financial terms of the deal were not disclosed.

 

The companies said that the combined products are expected to be available this summer. In addition, the companies will jointly develop applications and seminars as part of the marketing agreement.

 

GlycomIQ comprises kits, consumables, and informatics software for automated analysis of protein glycosylation.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.